Holistic Approach to Immune Checkpoint Inhibitor-Related Adverse Events

Immune checkpoint inhibitors (ICIs) block inhibitory molecules, such as cytotoxic T-lymphocyte-associated protein 4 (CTLA-4), programmed cell death protein 1 (PD-1), or its ligand, programmed cell death protein ligand 1 (PD-L1) and enhance antitumor T-cell activity. ICIs provide clinical benefits in...

Descripción completa

Detalles Bibliográficos
Autores principales: Poto, Remo, Troiani, Teresa, Criscuolo, Gjada, Marone, Giancarlo, Ciardiello, Fortunato, Tocchetti, Carlo Gabriele, Varricchi, Gilda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9005797/
https://www.ncbi.nlm.nih.gov/pubmed/35432346
http://dx.doi.org/10.3389/fimmu.2022.804597

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9005797/
https://www.ncbi.nlm.nih.gov/pubmed/35432346
http://dx.doi.org/10.3389/fimmu.2022.804597

Ejemplares similares